Search

everythinglearnresearchcommunity

for

Search:↓

The hair-growth formula with L-cystine helps protect and grow hair cells.

Low ferritin levels might be linked to telogen effluvium, but vitamin D levels are not.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

New treatments for hair loss are promising.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Cats lose fur due to various reasons, including allergies, infections, genetics, hormones, diet, cancer, stress, and some conditions are treatable while others are not.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Australian fur seals' fur shows high levels of pollutants, which may be linked to hair loss in young female seals.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Women with thinning hair have thinner hair strands than women without hair loss.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.